124I in PET imaging: Impact on quantification, radiopharmaceutical development and distribution

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 11, 2006, Pages 1247-1248

  Bockisch, Andreas ^a   Freudenberg, Lutz ^a   Rosenbaum, Sandra ^a   Jentzen, Walter ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123; IODINE 124; IODINE 131; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; TRACER; YTTRIUM 90;

COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EDITORIAL; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; RADIOISOTOPE DISTRIBUTION; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

IMAGE ENHANCEMENT; IODINE RADIOISOTOPES; ISOTOPE LABELING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 33750337574     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0208-1     Document Type: Editorial

References (5)

1. 2 targets. Appl Radiat Isot 2000;52:181-4
2. 124I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004;14:2092-8
3. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of nis gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2005;19:1-8
4. Eschmann SM, Reischl G, Bilger K, Kupferschlager J, Thelen MH, Dohmen BM, et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders bymeans of iodine-124 and PET. Eur J Nucl Med Mol Imaging 2002;29:760-7
5. 124I. Appl Radiat Isot 2002;56:673-9